
Structure Therapeutics Inc.
Structure Therapeutics Inc.(GPCR)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
gpcr · 股价预测 · 14 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$145
Consensus
$115
+211.2% upside
Low
$90.00
Median: $113.5 · Last Close: $36.87
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$114.75
211.2% upside
High Target
$145
293.3%
Low Target
$90
144.1%
Current Price
$36.87
as of today
Based on analyst price targets, the GPCR stock price prediction for the next 12 months ranges from $90 to $145. The consensus GPCR price forecast of $114.75 implies 211.2% upside from the current price of $36.87.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $36.33 | ↓ 1.47% |
1-day model range: $36.07–$36.59. Peak: $36.59 (-1.47%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GPCR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-27 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-01-22 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-01-20 | Guggenheim | Maintains | Buy→Buy |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-12 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-12 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-12-11 | Jefferies | Maintains | Buy→Buy |
| 2025-12-09 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Structure Therapeutics Inc. (GPCR) stock. Of the recent 47 rating actions, 0 were upgrades and 0 were downgrades. 14 analysts currently cover GPCR.
分析师推荐趋势
GPCR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$31M
↓ 83.2% YoY
Revenue Next Year
$0M
↓ 99.9% YoY
EPS This Year
$-1.39
EPS Next Year
$-1.94
↑ 39.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast GPCR EPS of $-1.39 for the current fiscal year, based on estimates from 9 analysts. The GPCR revenue forecast is $31M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GPCR 股价预测由两类独立数据源支撑:来自 14 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。GPCR 的共识目标价为 $114.75(+211.2% 上行空间),分析师共识为 Buy。
GPCR 的短期预测(明日)为 $36.33(-1.47%)。
Structure Therapeutics Inc. 在 NASDAQ 上市,代码 GPCR。GPCR 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
GPCR 预测 · 8 个问题根据 14 位华尔街分析师,GPCR 的 12 个月平均目标价为 $114.75,最高 $145.00、最低 $90.00。若有图表,中位目标价可在上方查看。相对当前价 $36.87,隐含约 +211.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.